Current Prices from Unicycive Therapeutics, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	UNCY	USD	13.06.2025 23:59	0,68 USD	0,64 USD +7,14 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-10,34 %	13,57 %	17,48 %	-4,63 %	4,03 %	-86,37 %

Company Profile for Unicycive Therapeutics, Inc. - Common Stock Share

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.

Company Data

Name Unicycive Therapeutics, Inc. - Common Stock

Company Unicycive Therapeutics, Inc.

Symbol UNCY

Website https://www.unicycive.com

Primary Exchange

NASDAQ

ISIN US90466Y1038

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Dr. Shalabh K. Gupta M.D., MPA

Market Capitalization 72 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 4300 El Camino Real, 94022 Los Altos

IPO Date 2021-07-12

Ticker Symbols

Name	Symbol
NASDAQ	UNCY

More Shares

Investors who Unicycive Therapeutics, Inc. - Common Stock hold also have the following shares in their portfolio:

DZ BANK CLN E.9360 Bond

SHARJAH SUK. 19/26 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog